Improving HIV Monitoring: A Thesis Reveals Alarming Multi-Resistance in Southern Countries

Emilande Guichet's thesis, defended at the Institute for Research and Development, highlights a 95% concordance between a new viral load test and the Abbott test, providing a solution for HIV monitoring in Southern countries. This research, validated by ABES/STAR, underscores the challenges related to treatment resistance and the importance of regular virological monitoring.

The fight against HIV in Southern countries faces major challenges, notably resistance to antiretroviral treatments. Fifteen years after their introduction, many patients fail to achieve viral suppression, compromising their health. Emilande Guichet's research sheds light on these critical issues, revealing multi-resistance in almost all patients with virological failure after first-line treatment.

The results show a 95% concordance between the new viral load test and the Abbott test, indicating better sensitivity. This advancement allows for better monitoring of patients, often asymptomatic, but presenting high viral loads. The lack of regular virological monitoring could lead to a new epidemic of resistant strains in sub-Saharan Africa.

The implications of this research are strategic for decision-makers and investors. Improving virological monitoring represents a significant opportunity to reduce costs associated with therapeutic failures. Decision-makers must support initiatives that enhance access to care and the quality of treatments while establishing partnerships to overcome infrastructure challenges.

« « Our data show multi-resistance in almost all patients with virological failure, highlighting the urgency of improving virological monitoring, » says Emilande Guichet. »

« « This research opens up perspectives for access to virological monitoring solutions, essential for public health decision-makers, » emphasizes the Lektaris team. »